Will therapy with psychadelic drugs become mainstream?

Could psilocybin, the active ingredient in magic mushrooms, play a role in the treatment of PTSD, OCD and eating disorders?

A global series of trials, including one in Tallaght, may add to the evidence that psilocybin can play a unique role in therapy.

Patrick Freyne talks to Conor Pope about the potential of psychedelic therapy and how decades of research were lost to the "war on drugs".

Hosted on Acast. See acast.com/privacy for more information.